Information on how to access prescribing information and adverse event reporting can be found at the bottom of the page.
Who is the CRESEMBA® patient?
CRESEMBA may be an appropriate treatment option for a range of different patients. These could include patients in need of oral therapy, those at risk of particular drug-drug interactions associated with other azoles or those with renal impairment.
Patient case studies illustrating use of CRESEMBA (isavuconazole) in a clinical setting
Lisa Nwankwo - Specialist Pharmacist, Antimicrobials
Patient case study illustrating use of isavuconazole in a clinical setting: A case of pulmonary mucormycosis
** This is an optional area where footnotes can live.
Lisa Nwankwo - Specialist Pharmacist, Antimicrobials
Patient case study illustrating use of isavuconazole in a clinical setting: Invasive aspergillosis in cystic fibrosis
** This is an optional area where footnotes can live.
Lisa Nwankwo - Specialist Pharmacist, Antimicrobials
Patient case study illustrating use of isavuconazole in a clinical setting: A complex ITU patient
** This is an optional area where footnotes can live.
Arunaloke Chakrabarti - President of Interntional Society of Human & Animal Mycology
Covid-19 Associated Mucormycosis: An Emerging At-Risk Patient Population
** This is an optional area where footnotes can live.
Nelun Perera, Consultant Microbiologist
Sharing clinical experience of CRESEMBA (isavuconazole) in the UK
Footnotes
AML acute myeloid leukaemia, HIV human immunodeficiency virus, CLL chronic lymphocytic leukaemia
Explore more
Invasive Aspergillosis
An overview of the SECURE trial for CRESEMBA (isavuconazole).
Learn more
Mucormycosis
An overview of the VITAL trial for CRESEMBA (isavuconazole).
Learn more
Prescribing Information
Cresemba (isavuconazole)
Great Britain
Cresemba (isavuconazole) 100mg hard capsules
Cresemba (isavuconazole) 200mg powder for concentrate for solution for infusion
Northern Ireland
Cresemba (Isavuconazole) 100mg hard capsules and Cresemba (Isavuconazole) 200mg powder for concentrate for solution for infusion
Vfend (voriconazole)
Great Britain
Vfend (voriconazole) 50mg film coated tablets
Vfend (voriconazole) 200mg film coated tablets
Vfend (voriconazole) 200mg powder for solution for infusion
Vfend (voriconazole) 40mg/ml powder for oral suspension
Northern Ireland
Vfend (voriconazole): 50mg film coated tablets, 200mg film coated tablets & 40mg/ml powder for oral suspension
Meronem (meropenem trihydrate)
Great Britain
Meronem (meropenem trihydrate)IV 1g
Meronem (meropenem trihydrate) IV 500mg
Northern Ireland
Meronem (meropenem trihydrate)IV 1g
Meronem (meropenem trihydrate) IV 500mg
Diflucan (fluconazole)
Great Britain
Diflucan (fluconazole) Prescribing Information - 10mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information - 150mg capsules
Diflucan (fluconazole) Prescribing Information - 200mg hard capsules
Diflucan (fluconazole) Prescribing Information - 40mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information - 50mg hard capsules
Northern Ireland
Diflucan (fluconazole) Prescribing Information - 10mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information - 150mg capsules
Diflucan (fluconazole) Prescribing Information - 200mg hard capsules
Diflucan (fluconazole) Prescribing Information - 40mg/ml powder for oral suspension
Diflucan (fluconazole) Prescribing Information - 50mg hard capsules
PP-CRB-GBR-1429 February 2022
Antifungal Stewardship
Support for your Programme
Access Pfizer
Training
For UK Healthcare Professionals*
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-3863. November 2021
No
OK, We will need you to sign in before we can determine if you are aligned with a Pfizer promotional colleague.This is an interstitial message to prompt a HCP before they login.
If you have already registered with pfizerpro.co.uk and select ‘yes’, you will be directed to the sign-in page where you will be required to enter your username and password.
Would you like to register or sign in now?